Ilmarinen Mutual Pension Insurance Co lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 31.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 160,400 shares of the healthcare conglomerate's stock after acquiring an additional 38,400 shares during the period. UnitedHealth Group accounts for approximately 0.7% of Ilmarinen Mutual Pension Insurance Co's holdings, making the stock its 18th biggest position. Ilmarinen Mutual Pension Insurance Co's holdings in UnitedHealth Group were worth $81,140,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in the stock. Howard Capital Management Group LLC acquired a new stake in UnitedHealth Group during the third quarter valued at approximately $341,000. Principal Financial Group Inc. raised its position in shares of UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after purchasing an additional 180,479 shares during the period. Jacobs Levy Equity Management Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $319,000. Texas Capital Bank Wealth Management Services Inc raised its holdings in UnitedHealth Group by 1.5% during the 3rd quarter. Texas Capital Bank Wealth Management Services Inc now owns 16,370 shares of the healthcare conglomerate's stock worth $9,571,000 after buying an additional 236 shares during the period. Finally, Temasek Holdings Private Ltd boosted its holdings in shares of UnitedHealth Group by 137.6% in the third quarter. Temasek Holdings Private Ltd now owns 161,656 shares of the healthcare conglomerate's stock worth $94,517,000 after buying an additional 93,618 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages recently commented on UNH. Cantor Fitzgerald restated an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Wells Fargo & Company decreased their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Finally, Barclays dropped their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $629.32.
View Our Latest Report on UnitedHealth Group
UnitedHealth Group Stock Performance
UnitedHealth Group stock traded down $15.50 during trading hours on Friday, reaching $524.94. 9,914,705 shares of the company were exchanged, compared to its average volume of 4,256,040. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The firm has a market cap of $480.17 billion, a price-to-earnings ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a 50-day moving average of $509.24 and a 200 day moving average of $541.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the firm posted $5.83 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group's dividend payout ratio is 54.19%.
Insider Buying and Selling
In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is currently owned by insiders.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.